What pharma companies need to know about the Inflation Reduction Act (IRA), with Emily Coriale, PharmD, LifeSci Consulting
Episode Summary In this episode, host Nick Mazing from AlphaSense interviews Emily Coriale, Senior Principal Pricing & Market Access Lead at LifeSci Consulting. They discuss the far-reaching implications of the Inflation Reduction Act (IRA) on the US healthcare system, with a particular focus on drug pricing and price negotiations between the US federal government and pharmaceutical companies, as well as the impact on health plans. Emily explains that the IRA is the most significant feder...